Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL D-BIOTIN INDUSTRY
2.1 Summary about D-Biotin Industry
2.2 D-Biotin Market Trends
2.2.1 D-Biotin Production & Consumption Trends
2.2.2 D-Biotin Demand Structure Trends
2.3 D-Biotin Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 1% Biotin
4.2.2 2% Biotin
4.2.3 Pure Biotin (>98%)
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Animal Feed
4.3.2 Pharma & Cosmetics
4.3.3 Food
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 1% Biotin
5.2.2 2% Biotin
5.2.3 Pure Biotin (>98%)
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Animal Feed
5.3.2 Pharma & Cosmetics
5.3.3 Food
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 1% Biotin
6.2.2 2% Biotin
6.2.3 Pure Biotin (>98%)
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Animal Feed
6.3.2 Pharma & Cosmetics
6.3.3 Food
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 1% Biotin
7.2.2 2% Biotin
7.2.3 Pure Biotin (>98%)
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Animal Feed
7.3.2 Pharma & Cosmetics
7.3.3 Food
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 1% Biotin
8.2.2 2% Biotin
8.2.3 Pure Biotin (>98%)
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Animal Feed
8.3.2 Pharma & Cosmetics
8.3.3 Food
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 1% Biotin
9.2.2 2% Biotin
9.2.3 Pure Biotin (>98%)
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Animal Feed
9.3.2 Pharma & Cosmetics
9.3.3 Food
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Zhejiang Medicine
10.1.2 SDM
10.1.3 Hegno
10.1.4 Shanghai Acebright
10.1.5 NUH
10.1.6 Anhui Tiger Biotech
10.1.7 Kexing Biochem
10.1.8 DSM
10.1.9 BASF
10.1.10 Allwell Industries
10.1.11 Zhejiang Shengda Bio-pharm Co., Ltd
10.1.12 BIOCAR
10.2 D-Biotin Sales Date of Major Players (2017-2020e)
10.2.1 Zhejiang Medicine
10.2.2 SDM
10.2.3 Hegno
10.2.4 Shanghai Acebright
10.2.5 NUH
10.2.6 Anhui Tiger Biotech
10.2.7 Kexing Biochem
10.2.8 DSM
10.2.9 BASF
10.2.10 Allwell Industries
10.2.11 Zhejiang Shengda Bio-pharm Co., Ltd
10.2.12 BIOCAR
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT